Trio Health, Inc.

Are you attending the 2025 AAAAI/WAO Joint Congress? We will be there! Come and join us! We are thrilled to have Dr. Williams present our research on APDS at the Clinical Aspects of Inborn Errors of Immunity session (located in Room 1A)!

Today, Trio Health is pleased to announce the appointment of Dave Bitner as Chief Commercial Officer. With nearly 30 years of experience in the pharmaceutical industry, Dave joins us after six years at Komodo Health, where he played a pivotal role in driving the company's success in the claims data space. Prior to Komodo, Dave was Head of Commercial Operations at Intercept Pharmaceuticals and held leadership roles at leading pharmaceutical companies such as Regeneron, Merck, and Pfizer. His expertise spans insights and analytics, business development, and brand strategy. Since joining Trio, Dave has already made significant strides in aligning our data services with the evolving needs of the industry. He has been instrumental in helping us leverage our expanded EMR access to 150 million patients. We are excited to see how his leadership will enhance our disease-specific solutions and drive impactful insights for both physicians and commercial teams. “I am excited to join Trio as they introduce new strategic partnerships and innovative clinical and commercial data solutions to the market,” said Dave. “I am particularly enthusiastic about the opportunity to pull EMR-level insights into tactical commercial solutions for our life sciences clients.” Welcome to Trio Health, Dave! View the full release here: https://lnkd.in/dG3_65bq

Trio Health was proud to present three research posters at AIDS 2024, the 25th International AIDS Conference, in late July. A huge thank you to Gilead Sciences and our analytics team for the support and collaboration on this real world research. Check out the posters or click the links below to read more. Outcomes in People with HIV (PWH) Who Resume or Switch to B/F/TAF Following an Antiretroviral Treatment Interruption (ATI): https://lnkd.in/ebY7y8fQ Characteristics and Outcomes of Virally Suppressed (VS) Treatment Experienced (VSTE) People with HIV (PWH): https://lnkd.in/etDetj4F Full citations report: https://lnkd.in/eZbkpk59

"The task now at hand is for the industry to shift our mindset from quantity of data to quality of data sources and the insights derived from RWD and RWE datasets." - Brent Clough Our CEO Brent Clough was invited on the RWD & RWE Club Podcast with Aaron Kamauu MD MS MPH?&?Matt Veatch last week. EP 140: Actioning Physician Networks for Clinical & Commercial Excellence. Real-world patients and their data are highly complex with many confounding factors that require us to think beyond continuous data aggregation. Learn how Trio Health's approach is solving these complex issues. Listen here or anywhere you prefer to listen to podcasts. Clubhouse - https://lnkd.in/eUunPqxV Spotify - https://lnkd.in/gDtEtf9N

Celebrating the first-year anniversaries of Isobel McEwen and Valeria Duran, MS Duran at Trio Health! As Research Analysts, both have become integral to our team, each bringing their unique strengths to our HIV research initiatives. Isobel has made substantial contributions to our HIV treatment and prevention research, enhancing the accuracy and depth of our studies with her detailed approach and meticulous attention to detail. Her work in navigating complex datasets has been vital in advancing our understanding of treatment patterns and patient outcomes. Valeria has applied her sharp analytical skills across various projects, showing a remarkable ability to manage complex data sets and derive meaningful insights that advance our real-world clinical research. Her proactive approach and commitment to excellence have been crucial in driving forward our initiatives and laying the groundwork for future innovations. Thank you, Isobel and Valeria, for your commitment and excellence over the past year!

Celebrating four years with Daniel Persons at Trio Health! Dan has been an integral part of our clinical data analysis team, focusing much of his expertise on advancing our RA research initiatives. His analytical skills and keen insights have greatly contributed to our understanding of RA treatment strategies. Dan's dedication to meticulous data analysis and his ability to distill complex information into actionable insights have made him a valued member of our team. His work not only supports ongoing research projects but has helped shape innovative approaches to RA care. Thank you Dan, for four years of outstanding contributions to our mission!

Introducing Trio360 We are proud to announce our newly re-branded solutions. Trio360 offers an end-to-end analytics and research service that leverages Trio Health’s extensive data capabilities to provide our clients with deep, actionable insights. From data visualization to complex analytics projects, Trio360 customizes its approach to meet your specific research objectives, ensuring you have the intelligence needed to make informed decisions. Why Trio360 Stands Apart Customized Research Support: Tailored analytics and research services to address unique business challenges and objectives. Collaborative Approach: Trio’s capabilities and experience allow us to build out full disease registries fit for your needs. Strategic Insights: From identifying market opportunities to supporting M&A decisions, Trio360 delivers strategic intelligence that can redefine your market position. Learn more at: https://lnkd.in/gNcGjRhg

Introducing SPECTRA We are proud to announce our newly re-branded solutions. SPECTRA offers comprehensive chart review services that transform unstructured data from patient records into actionable insights. By extracting detailed information from physician notes, lab results, and other sources, Spectra provides a deeper understanding of treatment outcomes, adherence patterns, and patient journeys. Why Choose Spectra for Your Chart Review Needs? Unmatched Detail: Access granular details about patient care and treatment outcomes previously buried in unstructured data. Customized Insights: Tailor chart reviews to your specific research questions, ensuring relevant and actionable findings. Efficient and Scalable: Leverage Trio Health’s expertise and technology for fast, accurate chart reviews, scalable to projects of any size. Learn more at: https://lnkd.in/gNcGjRhg

Introducing ENGAGE We are proud to announce our newly re-branded solutions. ENGAGE leverages Trio Health’s unique access to healthcare professionals to deploy targeted awareness and educational programs. This solution is designed to bridge the knowledge gap, ensuring that physicians are informed about the latest therapeutic advancements, leading to better patient care and outcomes. Key Benefits of ENGAGE TARGETED OUTREACH: Precisely targets physicians with tailored information, enhancing therapy adoption and patient management strategies. INFORMED DECISION-MAKING: Provides healthcare professionals with the data and insights needed to make informed treatment decisions. SCALABLE IMPACT: From small pilot programs to large-scale initiatives, Engage is designed to scale with your outreach goals and objectives. Learn more at: https://lnkd.in/gNcGjRhg

Did you know? Steroids are a common treatment for lupus but have side effects. It’s crucial to manage them effectively and support ongoing research for more treatments. This #WorldLupusDay let’s raise awareness of the need for more treatments for #lupus.